About Semmelweis Egyetem Pulmonológiai Klinika
Clinical Trials at Semmelweis Egyetem Pulmonológiai Klinika
During the past decade, Semmelweis Egyetem Pulmonológiai Klinika conducted 22 clinical trials. In the 10-year time frame, 22 clinical trials started and 15 clinical trials were completed, i.e. on
average, 68.2% percent of trials that started reached the finish line to date. In the past 5 years, 7 clinical trials started and 8 clinical trials were completed. i.e. 114.3%
of trials that started reached the finish line.
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Semmelweis Egyetem Pulmonológiai Klinika" #1 sponsor was "Hoffmann-La Roche" with 10 trials, followed by "Actelion" with 5 trials
sponsored, "Pfizer" with 4 trials sponsored, "Bristol-Myers Squibb" with 2 trials sponsored and "United Therapeutics"
with 2 trials sponsored. Other sponsors include 2 different institutions and
companies that sponsored additional 12 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Semmelweis Egyetem Pulmonológiai Klinika"
#1 collaborator was "Bristol-Myers Squibb" with 1 trials as a collaborator and "Ono Pharmaceutical Co. Ltd" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were
collaborators in the rest 2 trials.
Clinical Trials Conditions at Semmelweis Egyetem Pulmonológiai Klinika
According to Clinical.Site data, the most researched conditions in "Semmelweis Egyetem Pulmonológiai Klinika" are
"Carcinoma, Non-Small-Cell Lung" (4 trials), "Pulmonary Arterial Hypertension" (4 trials), "Non-Small Cell Lung Cancer" (3 trials), "Non-small Cell Lung Cancer" (2 trials) and "Small Cell Lung Cancer" (2 trials). Many other conditions were trialed in "Semmelweis Egyetem Pulmonológiai Klinika" in a lesser frequency.
Clinical Trials Intervention Types at Semmelweis Egyetem Pulmonológiai Klinika
Most popular intervention types in "Semmelweis Egyetem Pulmonológiai Klinika" are "Drug" (28 trials), "Biological" (4 trials) and "Other" (3 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (9 trials), "Carboplatin" (6 trials), "Docetaxel" (5 trials), "Pemetrexed" (5 trials) and "Atezolizumab" (3 trials). Other intervention names were less common.
Clinical Trials Genders at Semmelweis Egyetem Pulmonológiai Klinika
The vast majority of trials in "Semmelweis Egyetem Pulmonológiai Klinika" are
30 trials for "All" genders.
Clinical Trials Status at Semmelweis Egyetem Pulmonológiai Klinika
Currently, there are NaN active trials in "Semmelweis Egyetem Pulmonológiai Klinika".
undefined are not yet recruiting,
3 are recruiting,
5 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 20 completed trials in Semmelweis Egyetem Pulmonológiai Klinika,
undefined suspended trials,
and 1 terminated clinical trials to date.
Out of the total trials that were conducted in Semmelweis Egyetem Pulmonológiai Klinika, 0 "Phase 1"
clinical trials were conducted, 7 "Phase 2" clinical
trials and 20 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 1 trials, and there were
also 0 trials that are defined as “Not Applicable".